Loading...
OTCM
NHNKY
Market cap1.80bUSD
Jul 31, Last price  
11.22USD
1D
-1.92%
1Q
-9.22%
Jan 2017
0.99%
Name

Nihon Kohden Corp

Chart & Performance

D1W1MN
No data to show
P/E
16.20
P/S
1.24
EPS
104.41
Div Yield, %
Shrs. gr., 5y
-0.25%
Rev. gr., 5y
4.42%
Revenues
221.99b
+7.45%
83,807,000,00090,367,000,00096,679,000,000104,825,000,000109,123,000,000107,013,000,000113,380,000,000120,718,000,000132,538,000,000153,194,000,000160,803,000,000165,522,000,000166,285,000,000174,249,000,000178,799,000,000185,007,000,000199,727,000,000205,129,000,000206,603,000,000221,986,000,000
Net income
17.03b
-0.49%
6,562,000,0005,788,000,0005,052,000,0005,631,000,0004,610,000,0005,917,000,0006,573,000,0007,621,000,0009,151,000,00012,346,000,00011,142,000,00010,516,000,0009,149,000,0009,154,000,00011,191,000,0009,854,000,00018,243,000,00023,435,000,00017,110,000,00017,026,000,000
CFO
15.61b
P
3,542,000,0007,801,000,0005,882,000,0008,621,000,0004,123,000,00010,679,000,0005,892,000,0007,559,000,00013,189,000,0009,383,000,00012,505,000,00010,765,000,00011,356,000,00010,843,000,0009,819,000,0009,217,000,00013,945,000,00025,699,000,000-2,513,000,00015,607,000,000
Dividend
Sep 28, 20230.072074 USD/sh
Earnings
Aug 07, 2025

Profile

Nihon Kohden Corporation engages in research and development, production, sale, repair, and maintenance of medical electronic equipment in Japan, Americas, Europe, rest of Asia, and internationally. The company offers physiological measuring equipment, including electroencephalographs, electrocardiographs, evoked potential and electromyogram measuring instruments, and polygraphs for cath labs, as well as diagnostic information systems and related consumables, such as recording papers, electrodes and catheters, and maintenance services. It also provides patient monitors systems comprising central monitors, bedside monitors, wireless monitors, remote access software, and other equipment; and clinical information systems and related consumables, such as electrodes and sensors. In addition, the company offers treatment equipment, which include defibrillators, automated external defibrillators (AED), ventilators, pacemakers, anesthesia machines, cochlear implants, and related consumables and services, which include AED pads and batteries; and other medical equipment, including hematology and clinical chemistry analyzers, ultrasound diagnostic equipment, and equipment for research and others, as well as consumables, including test reagents, and installation and maintenance services. Additionally, it engages in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.
IPO date
Nov 02, 1961
Employees
5,751
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
221,986,000
7.45%
206,603,000
0.72%
Cost of revenue
199,615,000
185,482,000
Unusual Expense (Income)
NOPBT
22,371,000
21,121,000
NOPBT Margin
10.08%
10.22%
Operating Taxes
12,342,000
7,606,000
Tax Rate
55.17%
36.01%
NOPAT
10,029,000
13,515,000
Net income
17,026,000
-0.49%
17,110,000
-26.99%
Dividends
(5,968,000)
(5,733,000)
Dividend yield
0.89%
1.90%
Proceeds from repurchase of equity
(1,124,000)
(1,001,000)
BB yield
0.17%
0.33%
Debt
Debt current
615,000
424,000
Long-term debt
114,000
34,000
Deferred revenue
Other long-term liabilities
2,211,000
2,261,000
Net debt
(56,986,000)
(50,714,000)
Cash flow
Cash from operating activities
15,607,000
(2,513,000)
CAPEX
(3,626,000)
(8,256,000)
Cash from investing activities
(5,208,000)
(7,647,000)
Cash from financing activities
(6,968,000)
(7,485,000)
FCF
3,920,000
(15,608,000)
Balance
Cash
50,432,000
44,459,000
Long term investments
7,283,000
6,713,000
Excess cash
46,615,700
40,841,850
Stockholders' equity
171,122,000
167,072,000
Invested Capital
137,331,300
129,464,150
ROIC
7.52%
10.46%
ROCE
12.16%
12.38%
EV
Common stock shares outstanding
168,204
84,170
Price
4,004.00
11.53%
3,590.00
21.65%
Market cap
673,488,816
122.88%
302,170,300
-39.59%
EV
616,502,816
251,456,300
EBITDA
26,224,000
24,912,000
EV/EBITDA
23.51
10.09
Interest
24,000
10,000
Interest/NOPBT
0.11%
0.05%